434 articles – 313 references  [version française]
Short view
Prescreening tools for diabetes and obesity-associated dyslipidaemia: comparing BMI, waist and waist hip ratio. The D.E.S.I.R. Study.
Balkau B., Sapinho D., Petrella A., Mhamdi L., Cailleau M., Arondel D., Charles M.-A.
Eur J Clin Nutr 60, 3 (2006) 295-304 - http://www.hal.inserm.fr/inserm-00128602
 (16278693) 
Prescreening tools for diabetes and obesity-associated dyslipidaemia: comparing BMI, waist and waist hip ratio. The D.E.S.I.R. Study.
Beverley Balkau () 1, David Sapinho1, Anne Petrella2, Leila Mhamdi1, Martine Cailleau3, Dominique Arondel4, Marie-Aline Charles1, For the DESIR group collaboration(s)
1:  Epidémiologie cardiovasculaire et métabolique
INSERM : IFR69 – Université Paris XI - Paris Sud
Hôpital Paul Brousse 16, Avenue Paul Vaillant-Couturier 94807 VILLEJUIF CEDEX
France
2:  CES - Centre d'Examen de santé
Institut inter-régional pour la santé IRSA
Cholet
France
3:  D.E.S.I.R
Institut inter-régional pour la santé (IRSA)
La riche
France
4:  CES - Centre d'Examens de Santé
Institut inter-régional pour la santé IRSA
Chartres
France
Screening for undiagnosed diabetes and dyslipidaemia
OBJECTIVE: To compare the sensitivities of BMI, waist circumference and waist hip ratio (WHR) in identifying subjects who should be screened for diabetes and/or for obesity-associated dyslipidaemia. DESIGN: Cross-sectional study. SETTING: Central-western France. PARTICIPANTS: More than 3000 men and women, aged 40-64 years, from the French study: data from an epidemiological study on the insulin resistance syndrome (D.E.S.I.R.). MAIN OUTCOME MEASURES: Sensitivity and specificity for screened diabetes (fasting plasma glucose>or=7.0 mmol/l) and screened dyslipidaemia (triglycerides>or=2.3 mmol/l and/or HDL-cholesterol <0.9/1.1 mmol/l (men/women)) according to BMI, waist circumference and WHR. RESULTS: Sensitivities increased as more corpulent subjects were screened, but they increased slowly after screening the top 30%: body mass index (BMI)>or=27/26 kg/m(2) (men/women) or waist >or=96/83 cm or WHR>or=0.96/0.83. These values were chosen as thresholds. In men, BMI had a nonsignificantly higher sensitivity than waist or WHR for both diabetes and dyslipidaemia (77 vs 74 and 66% P<0.3, 0.09; 56 vs 54 and 49% P<0.5, 0.16). For women, waist had a slightly higher sensitivity than BMI or WHR (82 vs 77 and 77% P<0.8, 0.7) for diabetes; for dyslipidaemia, waist and WHR had similar sensitivities, higher than for BMI (65 and 67 vs 54% P<0.16, 0.13). CONCLUSIONS: We propose that for screening in a French population 40-64 years of age, the more obese 30% of the population, identified either by BMI, waist or WHR be screened for diabetes and obesity-associated dyslipidaemia.
Life Sciences/Food and Nutrition
Life Sciences/Health Care Sciences and Epidemiology
English
0954-3007

Article in peer-reviewed journal
10.1038/sj.ejcn.1602308
Eur J Clin Nutr
international
2006-03
60
3
295-304

Adult – Analysis of Variance – Body Composition – Body Mass Index – Cross-Sectional Studies – Diabetes Mellitus – Type 2 – Dyslipidemias – Female – France – Humans – Insulin Resistance – Male – Mass Screening – Middle Aged – Obesity – Risk Factors – Sensitivity and Specif
Attached file list to this document: 
PDF
balkau_text_EJCN.pdf(193.1 KB)
balkau_Figure_1_EJCN.pdf(53 KB)
BALKAU_Figure_2_EJCN.pdf(50.1 KB)
balkau_Table_1_EJCN.pdf(72.8 KB)
balkau_Table_2_EJCN.pdf(42 KB)
balkau_Table_3_EJCN.pdf(62.7 KB)
balkau_Table_4_EJCN.pdf(29.9 KB)
XHTML
index.xhtml(59.3 KB)